Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
36
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
14 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
43.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Gossamer Bio
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Phase III Trials And Global Collaborations Will Expand Treatment Horizons
Key Takeaways Successful Phase III study enrollment and collaboration enhance market reach, promising revenue growth through potential positive efficacy results and expanded indications. Anticipated first-in-class status and expanded dosing strategies could drive market adoption and earnings through competitive positioning and a broader patient base.
View narrative
US$7.75
FV
69.8% undervalued
intrinsic discount
62.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
11 days ago
author updated this narrative
Lanvin Group Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Operational Hurdles And Brand Shifts Will Reshape Luxury Market Appeal
Key Takeaways Revenue decline due to saturated luxury markets and creative transitions may hinder revenue growth and market positioning. Operational inefficiencies and economic uncertainties could impact net margins and delay profitability, affecting earnings projections.
View narrative
US$1.50
FV
41.1% overvalued
intrinsic discount
10.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
11 days ago
author updated this narrative
CommScope Holding Company
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
DOCSIS Rollout And Next-Gen Wi-Fi Will Empower Networks
Key Takeaways Innovation in next-generation broadband and enterprise networking is driving sustained revenue growth and improved margins through higher software and subscription adoption. Streamlined capital structure and resilient global operations position the company for improved shareholder returns and stable financial performance amid macroeconomic volatility.
View narrative
US$19.00
FV
17.8% undervalued
intrinsic discount
11.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
11 days ago
author updated this narrative
Healwell AI
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Healthcare Digitization Will Transform AI Software Services
Key Takeaways Refocusing on scalable AI software and strategic acquisitions positions Healwell to capitalize on global healthcare digitization, boosting margins, growth, and recurring revenues. Integration of advanced AI tools and active partnerships enhances customer retention, cross-selling, and operational efficiencies, supporting sustained value and industry leadership.
View narrative
CA$3.45
FV
59.7% undervalued
intrinsic discount
43.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
11 days ago
author updated this narrative
Beauty Health
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Premium Beauty Markets Will Face Risks And Rewards
Key Takeaways Overreliance on premium offerings and Hydrafacial leaves the company vulnerable to shifting consumer trends, economic pressures, and evolving competitive dynamics. Rising regulatory and sustainability demands may increase costs and suppress margins, hampering long-term revenue and earnings growth.
View narrative
US$1.88
FV
17.9% overvalued
intrinsic discount
3.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
11 days ago
author updated this narrative
Oncopeptides
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Agreements In Europe And Japan Will Unlock Global Markets
Key Takeaways Strategic agreements in Europe and potential licensing in Japan will unlock major markets, enhancing future earnings and revenue growth. Cost management alongside sales expansion in core European markets aims to achieve cash flow positivity, positively impacting net margins by 2026.
View narrative
SEK 3.25
FV
37.8% overvalued
intrinsic discount
117.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
Updated
narrative
DouYu International Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Digital Monetization And Mobile Entertainment Will Unlock Value
Key Takeaways Diversification into innovative segments and digital monetization is strengthening revenue streams and reducing reliance on declining areas. Operational cost optimization and AI-driven efficiency initiatives are supporting margin improvement and earnings resilience.
View narrative
US$7.35
FV
12.6% overvalued
intrinsic discount
-4.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
11 days ago
author updated this narrative
Aspen Aerogels
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Cost Optimization And Industrial Demand Will Shape Future Markets
Key Takeaways Cost reductions and process improvements are enhancing profitability and positioning the company for stronger earnings even at modest revenue levels. Strategic focus on EV thermal barriers and U.S.-based manufacturing aligns with regulatory trends, supporting future growth and market share expansion.
View narrative
US$9.58
FV
26.9% undervalued
intrinsic discount
8.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
27
users have followed this narrative
5 days ago
author updated this narrative
Anaergia
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Decarbonization Trends Will Drive European Infrastructure Expansion
Key Takeaways Expansion in Europe and improved project execution boost growth, earnings quality, and market share amid strong decarbonization demand and supportive policy trends. Scalable solutions and recurring contracts with major customers increase cash flow predictability and enhance long-term earnings visibility.
View narrative
CA$3.00
FV
39.7% undervalued
intrinsic discount
35.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies